Our researchers are leading seminal work on pharmacogenetic testing for asthma, performing genetic epidemiological studies that focus on large, real-life population. Highlights include:
A study that evaluated the effectiveness of recently developed pharmacogenetic tests that predict which patients are at highest risk for not responding to the two most commonly used medications for asthma, B2-agonist and inhaled corticosteroids.
A current study to validate a pharmacogenetic test using a cohort of asthma patients who have been treated with inhaled corticosteroids.
Related News and Recent Publications
- Wu AC, Himes BE, Lasky-Su J, Litonjua A, Peters SP, Lima J, Kubo M, Tamari M, Nakamura Y, Qiu W, Weiss ST, Tantisira K. Inhaled corticosteroid treatment modulates ZNF432 gene variant's effect on bronchodilator response in asthmatics. J Allergy Clin Immunol. 2014 Mar;133(3):723-8.e3. Epub 2013 Nov 23.
For more information on the Center's work please contact Kelly Horan.